Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-03

FDA Approved: PITAVASTATIN — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved an original ANDA for pitavastatin calcium from Upsher-Smith Laboratories, making a generic pitavastatin product available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PITAVASTATIN CALCIUM (PITAVASTATIN CALCIUM)

Snippet

ORIG AP for PITAVASTATIN (PITAVASTATIN CALCIUM)